An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

This latest vaccine protects against both earlier strains, including the Omicron variant, and the newly spreading JN1 variant, which has made its way around the globe, including Israel.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons.

We asked experts about the new vaccines and what we can expect if they're approved. Professor Purcell said the first Omicron strain was an "escape" variant that required an updated vaccine.

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

However, the quick rise of this new mutation, which is a combination of two previous omicron strains, may mean the vaccines prepared to bolster people in the colder months won’t be as effective.

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.